Sie suchten nach: cu afectare ganglionara (Rumänisch - Englisch)

la pacienţii cu afectare
in severe hepatically impaired patients (child-pugh classification c), mean values for sirolimus auc and t1/ 2 were increased 210% and 170% respectively, and cl/ f was

pacienţi cu afectare renală
patients with renal disease

la pacienţi cu afectare hepatică.
liver impairment.

vasculită cu afectare renală tranzitorie
vasculitis with transient renal involvement

paciente cu afectare renală severă.
patients with severe renal impairment.

vasculită, posibil asociată cu afectare renală tranzitorie
musculoskeletal and connective tissue disorders

cu afecţiuni convulsivante
with seizure disorders

pacienţii cu afecţiuni care
exercised in patients with

pacienţi cu afecţiune renală
patients with kidney disease

pacienţi cu afecţiune a ficatului
patients with liver disease

pacienţii cu afecţiuni cardiace preexistente
patients with pre-existing cardiac conditions

pacienţi cu afecţiuni imunitare specifice.
patients with certain immune disorders.

pacienţi cu afecţiuni medicale severe, debilitante
patients with severe, debilitating medical conditions

prevenirea tromboemboliei venoase la pacienţii cu afecţiuni medicale
prevention of venous thromboembolism in medically ill patients

dozele trebuie reduse la pacienţii cu afecţiuni renale.
the doses need to be reduced in patients with kidney problems.

este contraindicată administrarea dynastat pacienţilor cu afecţiuni hepatice severe.
dynastat must not be used in patients with severe liver problems.

pacienţi cu afecţiuni renale (vezi 5. 2):
patients with impaired renal function (see 5.2):

bronhospasm (predominant la pacienţii cu afecţiuni bronhospastice preexistente)
bronchospasm (predominantly in patients with pre-existing bronchospastic disease)

bronhospasm (predominant la pacienţii cu afecţiuni bronhospastice preexistente), astm
bronchospasm (predominantly in patients with pre-existing bronchospastic disease), asthma